Last reviewed · How we verify

NCT04206514: SPARQ_PACK

Improving Person Centered Care for Post Abortion Patients in Kenya

Completed NA Last updated 14 January 2020
What this trial tests

NA trial testing Person Centered Care - Post Abortion Support in Reproductive Health in 371 participants. Completed in 18 December 2018.

Timeline
27 August 2018
Primary endpoint
18 December 2018
18 December 2018

Quick facts

Lead sponsorUniversity of California, San Francisco
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment371
Start date27 August 2018
Primary completion18 December 2018
Estimated completion18 December 2018
Sites1 location across Kenya

Drugs / interventions tested

Conditions studied

Sponsor

University of California, San Francisco

Who can join

Adults 15 to 49, female only, with Reproductive Health. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to understand the effect of a phone based post-abortion intervention on the experience of post-abortion care.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Improving stigma and psychosocial outcomes among post-abortion Kenyan women attending private clinics: A randomized controlled trial of a person-centered mobile phone-based intervention.
    Sudhinaraset M, Landrian A, Cotter SY, Golub G, et al · · 2022 · cited 6× · PMID 35749557 · DOI 10.1371/journal.pone.0270637

Verify or expand the search:

Other recruiting trials for Reproductive Health

Currently open trials in the same condition.

Other University of California, San Francisco trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04206514.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing